Repligen
RGEN
#1738
Rank
โ‚น1.144 T
Marketcap
โ‚น18,027
Share price
2.48%
Change (1 day)
34.81%
Change (1 year)
Categories

Repligen (RGEN) - P/B ratio

P/B ratio as of October 2026 : 5.69

According to Repligen 's latest financial reports the company has a price-to-book ratio of 15.3041.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Repligen - P/B ratio (from 2001 to 2026)

P/B ratio by year

Year P/B ratio Change
2026-12-31N/A-100%
2025-12-314.396.27%
2024-12-314.13-19.1%
2023-12-315.113.84%
2022-12-314.92-41.2%
2021-12-318.3722.02%
2020-12-316.8650.85%
2019-12-314.5520.81%
2018-12-313.7640.83%
2017-12-312.67-56.75%
2016-12-316.18-18.64%
2015-12-317.5930.75%
2014-12-315.8138.56%
2013-12-314.1980%
2012-12-312.3348.22%
2011-12-311.57-25.05%
2010-12-312.1011.94%
2009-12-311.8713.48%
2008-12-311.65-45.55%
2007-12-313.03-10.17%
2006-12-313.37-27.58%
2005-12-314.6632.78%
2004-12-313.51-18.64%
2003-12-314.3135.83%
2002-12-313.17

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Pfizer
PFE
1.99-65.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
4.94-13.23%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
17.8 212.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
5.52-2.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-1.62-128.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-9.00-258.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
4.02-29.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
5.41-4.93%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
1.74-69.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
6.22 9.32%๐Ÿ‡บ๐Ÿ‡ธ USA